These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency. Schütt SM; Schumacher M; Holterhus PM; Felgenhauer S; Hiort O Eur J Endocrinol; 2003 Oct; 149(4):317-21. PubMed ID: 14514346 [TBL] [Abstract][Full Text] [Related]
3. Growth hormone secretion in poorly growing children with renal hypophosphataemic rickets. Saggese G; Baroncelli GI; Bertelloni S; Perri G Eur J Pediatr; 1994 Aug; 153(8):548-55. PubMed ID: 7957399 [TBL] [Abstract][Full Text] [Related]
4. Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic rickets. Baroncelli GI; Bertelloni S; Sodini F; Galli L; Vanacore T; Fiore L; Saggese G Pediatr Endocrinol Rev; 2004 Jun; 1(4):361-79. PubMed ID: 16437029 [TBL] [Abstract][Full Text] [Related]
5. X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone. Reusz GS; Miltényi G; Stubnya G; Szabó A; Horváth C; Byrd DJ; Péter F; Tulassay T Pediatr Nephrol; 1997 Oct; 11(5):573-7. PubMed ID: 9323282 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Drezner MK; Lyles KW; Haussler MR; Harrelson JM J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520 [TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. ADHR Consortium Nat Genet; 2000 Nov; 26(3):345-8. PubMed ID: 11062477 [TBL] [Abstract][Full Text] [Related]
8. Growth and metabolic control during puberty in girls with X-linked hypophosphataemic rickets. Sochett E; Doria AS; Henriques F; Kooh SW; Daneman A; Mäkitie O Horm Res; 2004; 61(5):252-6. PubMed ID: 15031616 [TBL] [Abstract][Full Text] [Related]
9. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion. Živičnjak M; Schnabel D; Staude H; Even G; Marx M; Beetz R; Holder M; Billing H; Fischer DC; Rabl W; Schumacher M; Hiort O; Haffner D; J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic osteomalacia: is there a new phosphate regulating hormone? Nelson AE; Robinson BG; Mason RS Clin Endocrinol (Oxf); 1997 Dec; 47(6):635-42. PubMed ID: 9497867 [TBL] [Abstract][Full Text] [Related]
11. X-linked hypophosphatemia: molecular biology and treatment controversies. Thabet MA; Truchina O; Chan JC Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(3):180-7. PubMed ID: 8042500 [TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity. Lyles KW; Drezner MK J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432 [TBL] [Abstract][Full Text] [Related]
13. [From gene to disease; hypophosphataemic rickets and the PHEX gene]. Jansen M; van Dael CM; Verrijn Stuart AA; van der Hout AH; Rump P Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1390-4. PubMed ID: 16841587 [TBL] [Abstract][Full Text] [Related]
14. Mineral content of different areas of human dentin in hypophosphataemic vitamin D-resistant rickets. Hietala EL; Larmas MA J Biol Buccale; 1991 Jun; 19(2):129-34. PubMed ID: 1657902 [TBL] [Abstract][Full Text] [Related]
15. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245 [TBL] [Abstract][Full Text] [Related]
16. Acquired hypophosphataemic vitamin D resistant rickets in black children. Pettifor JM; Ross FP; Quirk M; Moodley GP; Cavaleros M Bone Miner; 1986 Sep; 1(4):307-19. PubMed ID: 2849486 [TBL] [Abstract][Full Text] [Related]
17. Early biochemical findings in familial hypophosphataemic, hyperphosphaturic rickets and response to treatment. Moncrieff MW Arch Dis Child; 1982 Jan; 57(1):70-2. PubMed ID: 7065698 [TBL] [Abstract][Full Text] [Related]
18. Familial hypophosphataemic rickets affecting a father and his two daughters: a case report. Ekpebegh CO; Blanco-Blanco E West Afr J Med; 2010; 29(4):271-4. PubMed ID: 20931517 [TBL] [Abstract][Full Text] [Related]
19. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study. Carpenter TO; Keller M; Schwartz D; Mitnick M; Smith C; Ellison A; Carey D; Comite F; Horst R; Travers R; Glorieux FH; Gundberg CM; Poole AR; Insogna KL J Clin Endocrinol Metab; 1996 Jun; 81(6):2381-8. PubMed ID: 8964881 [TBL] [Abstract][Full Text] [Related]
20. Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. Adams JS; Gacad MA; Singer FR J Clin Endocrinol Metab; 1984 Sep; 59(3):556-60. PubMed ID: 6547728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]